New South Capital Management Inc. Sells 25,475 Shares of Avantor, Inc. (NYSE:AVTR)

New South Capital Management Inc. trimmed its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 1.8% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,379,767 shares of the company’s stock after selling 25,475 shares during the quarter. Avantor accounts for 1.5% of New South Capital Management Inc.’s holdings, making the stock its 25th biggest position. New South Capital Management Inc.’s holdings in Avantor were worth $35,695,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Versant Capital Management Inc increased its stake in Avantor by 2,003.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. increased its stake in Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after purchasing an additional 1,391 shares in the last quarter. UMB Bank n.a. bought a new stake in Avantor during the 3rd quarter worth approximately $49,000. Nisa Investment Advisors LLC increased its stake in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after purchasing an additional 835 shares in the last quarter. Finally, GAMMA Investing LLC increased its stake in Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after purchasing an additional 1,285 shares in the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Stock Performance

Avantor stock traded down $0.11 during mid-day trading on Tuesday, hitting $22.19. 303,713 shares of the company’s stock traded hands, compared to its average volume of 6,410,494. The firm has a 50 day simple moving average of $24.84 and a two-hundred day simple moving average of $24.08. Avantor, Inc. has a fifty-two week low of $18.41 and a fifty-two week high of $28.00. The stock has a market cap of $15.10 billion, a price-to-earnings ratio of 48.48, a P/E/G ratio of 2.73 and a beta of 1.35. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Insiders Place Their Bets

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on AVTR shares. TD Cowen raised their price target on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Robert W. Baird decreased their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Stifel Nicolaus raised their price target on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Finally, Barclays cut their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Avantor currently has an average rating of “Moderate Buy” and a consensus price target of $27.57.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.